focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.40
Ask: 70.40
Change: 0.40 (0.58%)
Spread: 2.00 (2.924%)
Open: 69.00
High: 69.00
Low: 69.00
Prev. Close: 69.00
CCEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

27 May 2022 15:30

RNS Number : 1330N
Coca-Cola Europacific Partners plc
27 May 2022
 

Coca-Cola Europacific Partners plc - Results of 2022 Annual General Meeting

 

The Annual General Meeting of Coca-Cola Europacific Partners plc (the "Company") was held at Pemberton House, Bakers Road, Uxbridge UB8 1EZ on 27 May 2022.

 

All 29 resolutions put to the members were passed on a poll. Accordingly, resolutions 1 to 24 were passed as ordinary resolutions and resolutions 25 to 29 were passed as special resolutions.

 

The results of the polls are set out below:

 

Resolution

For (see note 1)

Against (see note 1)

Issued share capital represented by votes (see note 2) %

Votes withheld (see note 3)

Votes

%

Votes

%

1

Receipt of the Report and Accounts

393,387,484

100.00

18,205

0.00

86.12

170,467

2

Approval of the Directors' Remuneration Report

328,840,214

86.18

52,743,916

13.82

83.54

11,992,026

3

Re-election of Manolo Arroyo as a director of the Company

330,432,926

83.97

63,069,542

16.03

86.15

73,688

4

Re-election of Jan Bennink as a director of the Company

391,720,370

99.55

1,782,410

0.45

86.15

73,376

5

Re-election of John Bryant as a director of the Company

388,369,790

98.70

5,128,997

1.30

86.14

77,369

6

Re-election of José Ignacio Comenge as a director of the Company

390,024,095

99.14

3,386,806

0.86

86.13

165,255

7

Re-election of Christine Cross as a director of the Company

376,108,892

95.81

16,468,250

4.19

85.94

999,014

8

Re-election of Damian Gammell as a director of the Company

391,135,623

99.40

2,375,183

0.60

86.15

65,350

9

Re-election of Nathalie Gaveau as a director of the Company

386,580,076

98.24

6,922,132

1.76

86.15

73,948

10

Re-election of Álvaro Gómez -Trénor Aguilar as a director of the Company

390,047,485

99.15

3,362,025

0.85

86.12

166,646

11

Re-election of Thomas H. Johnson as a director of the Company

366,960,714

93.27

26,498,656

6.73

86.14

116,786

12

Re-election of Dagmar Kollmann as a director of the Company

386,511,521

98.22

6,989,441

1.78

86.14

75,194

13

Re-election of Alfonso Líbano Daurella as a director of the Company

390,052,709

99.15

3,353,376

0.85

86.12

170,071

14

Re-election of Mark Price as a director of the Company

378,075,655

96.08

15,425,114

3.92

86.14

75,387

15

Re-election of Mario Rotllant Solá as a director of the Company

342,959,508

87.16

50,541,454

12.84

86.14

75,194

16

Re-election of Brian Smith as a director of the Company

387,575,164

98.50

5,921,628

1.50

86.14

79,364

17

Re-election of Dessi Temperley as a director of the Company

388,999,021

98.86

4,501,231

1.14

86.14

75,904

18

Re-election of Garry Watts as a director of the Company

390,245,303

99.18

3,212,533

0.82

86.14

118,320

19

Reappointment of the Auditor

387,457,799

98.46

6,051,766

1.54

86.15

66,591

20

Remuneration of the Auditor

391,255,176

99.43

2,228,779

0.57

86.14

92,201

21

Political Donations

392,280,814

99.86

556,382

0.14

86.00

738,960

22

Authority to allot new shares

387,466,967

98.46

6,044,898

1.54

86.15

64,291

23

Waiver of mandatory offer provisions set out in Rule 9 of the Takeover Code (see note 4)

187,221,383

82.48

39,759,595

17.52

49.69

166,595,178

24

Employee Share Purchase Plan

393,390,559

99.96

145,611

0.04

86.15

39,986

25

General authority to disapply pre-emption rights

392,532,173

99.90

386,792

0.10

86.02

657,191

26

General authority to disapply pre-emption rights in connection with an acquisition or specified capital investment

391,258,798

99.56

1,718,398

0.44

86.03

598,960

27

Authority to purchase own shares on market

392,327,304

99.81

745,187

0.19

86.05

503,665

28

Authority to purchase own shares off market

392,034,567

99.74

1,027,395

0.26

86.05

514,194

29

Notice period for general meetings other than annual general meetings

383,791,696

97.53

9,705,622

2.47

86.14

78,838

 

Notes:

 

1

Votes "For" and "Against" are expressed as a percentage of votes received.

 

2

As at 12.00pm on Wednesday 25 May 2022, the time by which shareholders who wanted to attend, speak and vote at the AGM must have been entered on the Company's register of members, there were 456,789,240 ordinary shares in issue.

 

3

A "Vote Withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.

 

4

Resolution 23 was put to the AGM as a resolution of the shareholders of the Company other than Olive Partners, S.A. ("Olive") or any concert party of Olive.

 

In particular, in accordance with Section 6(A) of Appendix 1 to the Takeover Code, the Company announces that shareholders approved resolution 23, setting out the terms of the waiver of mandatory offer provisions in Rule 9 of the Takeover Code (the "Waiver").

 

Olive is currently interested in 166,128,987 shares in the Company and the Waiver does not entitle Olive to be interested in a greater number of shares. The Waiver would allow Olive's interest in shares as a percentage of the Company's total shares to increase as a result of the exercise of the Company's authorities to purchase its own shares, but only to the extent that the resulting interest of Olive, together with any concert parties, in the shares of the Company did not then exceed 40.4114%.

 

In accordance with Listing Rule 14.3.6R, copies of the resolutions that do not constitute ordinary business at an annual general meeting will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

CONTACTS

 

Company Secretariat

Clare Wardle

T +44 (0)20 7355 8406

Investor Relations

Sarah Willett

T +44 (0)7970 145 218

Media Relations

Shanna Wendt

T +44 (0)7976 595 168

 

 

 

ABOUT CCEP

 

Coca-Cola Europacific Partners is one of the leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving 600 million consumers and helping 1.75 million customers across 29 countries grow. We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support. The Company is currently listed on Euronext Amsterdam, the NASDAQ Global Select Market, London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP.

 

For more information about CCEP, please visit www.cocacolaep.com & follow CCEP on Twitter at @CocaColaEP

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEALSXAEFAEFA
Date   Source Headline
30th Sep 20212:00 pmRNSDirector/PDMR Shareholding
17th Sep 202112:30 pmRNSBlock listing Interim Review
9th Sep 20215:00 pmRNSDirector/PDMR Shareholding
7th Sep 20211:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSResults for the six months ended 2 July 2021
1st Sep 20211:00 pmRNSTotal Voting Rights
20th Aug 20219:30 amRNSDirector/PDMR Shareholding
2nd Aug 20211:30 pmRNSTotal Voting Rights
28th Jul 20214:35 pmRNSPrice Monitoring Extension
20th Jul 202111:30 amRNSDirector/PDMR Shareholding
2nd Jul 20212:00 pmRNSDirector/PDMR Shareholding
1st Jul 20214:30 pmRNSTotal Voting Rights
23rd Jun 20213:00 pmRNSDirector/PDMR Shareholding
11th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20211:00 pmRNSDirector/PDMR Shareholding
1st Jun 20213:00 pmRNSTotal Voting Rights
27th May 202112:00 pmRNSResult of AGM
20th May 20211:00 pmRNSDirector/PDMR Shareholding
13th May 20212:45 pmRNSLetter to Shareholders
11th May 202112:30 pmRNSInvestor event following acquisition of Amatil
11th May 20217:00 amRNSQ1 2021 Trading Update
10th May 202111:00 amRNSChange of Name
4th May 20212:00 pmRNSTotal Voting Rights
27th Apr 20214:36 pmRNSPrice Monitoring Extension
21st Apr 20215:30 pmRNSDirector/PDMR Shareholding
21st Apr 20217:00 amRNSAnnounces new company name and investor event
20th Apr 20218:10 amRNSCCEP Unaudited Pro Forma Combined Financial Info
15th Apr 20211:30 pmRNSNotice of AGM
15th Apr 20218:04 amRNSCCEP confirms regulatory approval from NZ OIO
13th Apr 202111:00 amRNSDirectorate Change
1st Apr 20213:00 pmRNSTotal Voting Rights
31st Mar 20213:22 pmRNSUpdate re Coca-Cola Amatil Financing
24th Mar 202112:00 pmRNSDirector/PDMR Shareholding
17th Mar 20216:00 pmRNSDirector/PDMR Shareholding
17th Mar 20216:00 pmRNSBlock listing Interim Review
12th Mar 20215:31 pmRNSAnnual Financial Report
12th Mar 20217:00 amRNSScheme booklet registered by Coca-Cola Amatil
1st Mar 20214:00 pmRNSTotal Voting Rights
24th Feb 202111:00 amRNSDirector/PDMR Shareholding
15th Feb 20217:00 amRNSBest and final offer to acquire Coca-Cola Amatil
11th Feb 20217:00 amRNSPreliminary Unaudited Results Q4 & FY 2020
1st Feb 20213:00 pmRNSTotal Voting Rights
1st Feb 20217:00 amRNSCCEP receives FIRB approval to acquire CCL
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 202111:00 amRNSDirector/PDMR Shareholding
4th Jan 20212:30 pmRNSTotal Voting Rights
4th Jan 20211:30 pmRNSCoca-Cola European Partners plc Home Member State
23rd Dec 20201:00 pmRNSDirector/PDMR Shareholding
14th Dec 20204:30 pmRNSDirector/PDMR Shareholding
11th Dec 202011:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.